Medicare beneficiaries who qualify for the Medicare Low-Income Subsidy Program could be eligible this year to pay no more than $2.50 for generic drugs and $6.30 for brand name drugs, according to a ...

Medicare Advantage plans can drive significant, sustainable, and scalable improvements to health outcomes; reduce cost; and boost retention and top-line revenue by enrolling beneficiaries into the ...

A combination of government policies and market trends is causing significant turmoil in the Prescription Drug Plan (PDP) market, especially for plans that serve beneficiaries who receive the Medicare ...

This is the latest in the Health Affairs Forefront featured topic, Medicare and Medicaid Integration. The featured topic includes analysis, proposals, and commentary that will inform policies on the ...

Q. Is there an application open season to apply for the Medicare prescription drug low-income subsidy? A. No. An open season exists for enrolling in a Medicare prescription drug coverage (Part D) ...

Near low-income Medicare beneficiaries experience significant affordability challenges, facing higher financial burdens and medical debt compared to other income groups. Despite similar health status ...

Debates about Medicare’s future too often ignore two important facts about the people who rely on Medicare. First, about half of the seniors and people with disabilities who rely on Medicare have ...

Patients with cancer who participated in the Medicare Low-Income Subsidy program were less likely to receive any systemic cancer therapy compared with patients not participating in the program. Among ...

While it may seem intuitive that people would die without life-saving medications, Penn and Harvard researchers have connected losing a federally funded prescription drug assistance program and an ...

Losing a Medicare Part D subsidy is associated with higher mortality rates among low-income older adults, according to new research published in the New England Journal of Medicine by University of ...